EUROFINS SCIENT Share Holder Equity 2018-2024 | ERFSF

EUROFINS SCIENT share holder equity for the quarter ending December 31, 2024 was $5.827B, a 17.66% increase year-over-year.

  • EUROFINS SCIENT share holder equity for 2024 was $5.827B, a 4.79% increase from 2023.
  • EUROFINS SCIENT share holder equity for 2023 was $5.56B, a 8.79% increase from 2022.
  • EUROFINS SCIENT share holder equity for 2022 was $5.111B, a 7.64% decline from 2021.

EUROFINS SCIENT Share Holder Equity 2018-2024 | ERFSF

  • EUROFINS SCIENT share holder equity for 2024 was $5.827B, a 4.79% increase from 2023.
  • EUROFINS SCIENT share holder equity for 2023 was $5.56B, a 8.79% increase from 2022.
  • EUROFINS SCIENT share holder equity for 2022 was $5.111B, a 7.64% decline from 2021.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$134.6B
CVS Health (CVS)$78B
Elevance Health (ELV)$62.3B
Cencora (COR)$56.7B
DiDi Global (DIDIY)$26.2B
Labcorp Holdings (LH)$20.3B
Natera (NTRA)$19.2B
BioMerieux (BMXMF)$16.3B
CochLear (CHEOY)$13B
Solventum (SOLV)$12.5B
ICON (ICLR)$11.3B
Revvity (RVTY)$10.7B
Viatris (VTRS)$10.4B
Medpace Holdings (MEDP)$8.9B
Sonic Healthcare (SKHHY)$8.8B
Avantor (AVTR)$8.4B
HealthEquity (HQY)$8.4B
Charles River Laboratories (CRL)$7.4B
Caris Life Sciences,�Inc (CAI)$7.2B
Amplifon S.p.A (AMFPF)$5.4B
Bausch + Lomb (BLCO)$4.9B
BrightSpring Health Services (BTSG)$3.5B
Sotera Health (SHC)$3.1B
Surgery Partners (SGRY)$2.9B
Concentras Parent (CON)$2.6B
Alignment Healthcare (ALHC)$2.5B
Organon (OGN)$2.5B
GeneDx Holdings (WGS)$2.2B
Progyny (PGNY)$2B
PACS (PACS)$1.8B